Literature DB >> 20171145

Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome.

Mariella Baldini1, Emanuele Bartolini, Sara Gori, Enrica Bonanni, Mirco Cosottini, Alfonso Iudice, Luigi Murri.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is known to occur after solid organ transplantation, and is caused by immunosuppressive agents such as tacrolimus. PRES onset usually occurs within the first 2months after liver transplantation. Clinical findings include seizures, headache, focal neurological deficits, visual disturbances, and altered mental status. These are associated with characteristic imaging features of subcortical white matter lesions on brain MRI. Atypical localizations of this posterior leukoencephalopathy have been reported. Expeditious recognition of the syndrome may lead to a complete recovery. Abnormalities of EEG during follow-up might be associated with unfavorable seizure outcome, even when neuroimaging changes resolve. We report a case of late-onset PRES with atypical localization following liver transplantation. The patient developed epilepsy despite resolution of MRI lesions at 8 months of follow-up. EEG was a prognostic factor of seizure persistence, suggesting an incomplete recovery of brain lesions in contrast to neuroimaging findings. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171145     DOI: 10.1016/j.yebeh.2010.01.014

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  PRES-ing for Answers About Long-Term Seizure Risk in Patients With Posterior Reversible Encephalopathy Syndrome.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

3.  The importance of neurophysiological assessment in posterior reversible encephalopathy syndrome: a case report of an eclamptic woman.

Authors:  S Maccora; C M Ministeri; R Fabbri; P G Fabbri
Journal:  Neurol Sci       Date:  2013-06-07       Impact factor: 3.307

4.  Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns.

Authors:  Oliver Kastrup; Markus Gerwig; Markus Frings; Hans-Christoph Diener
Journal:  J Neurol       Date:  2011-12-22       Impact factor: 4.849

Review 5.  Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.

Authors:  Sheng Chen; Jun Hu; Liang Xu; Dixon Brandon; Jun Yu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 6.  Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.

Authors:  Turun Song; Zhengsheng Rao; Qiling Tan; Yang Qiu; Jinpeng Liu; Zhongli Huang; Xianding Wang; Tao Lin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  Acute symptomatic seizure due to tacrolimus-related encephalopathy after liver transplantation: two case reports.

Authors:  Yao Li; Haijiu Wang; Dongdong Han; Zhixin Wang; Li Zhang; Shiwei Yang; Qiang Wang; Hao Wen; Haining Fan
Journal:  J Int Med Res       Date:  2019-11-10       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.